About

Antibody therapeutics have become a major component of modern oncology and continuous innovations are rapidly reshaping the field. Advances in antibody discovery and engineering, immune engagement, targeted delivery, molecular imaging and analytical technologies are creating new opportunities to better characterize tumors and develop more precise therapeutic strategies.

The Antibody Innovation Summit 2026 is built around one central question: how can emerging antibody technologies address unmet clinical needs to reach meaningful patient impact?

Under the theme “Technologies with Patient Impact: The Latest Advances in Antibody Innovation,” this summit bridges clinical needs with advances in antibody research and therapeutic development. Clinicians, academic researchers and industry experts will share their perspectives on emerging approaches, their current limitations and the conditions required to drive them closer to clinical application.

Join biotechnology companies, CROs, technology providers and scientific and medical experts for a full day of expert talks, case studies and a panel discussion on September 22, 2026, at The Hive – PSCC, Villejuif.

The event is free to attend, but registration is required due to limited capacity.